Chemically coated, ceramic implants successfully guided the regrowth of missing bone in lab animals while “steadily dissolving,” researchers report.
Surgeons and scientists at NYU School of Medicine and NYU College of Dentistry say their implanted scaffolds were naturally absorbed by the test animals’ bodies as new bone gradually replaced the devices. The research team describes its progress in a series of reports, the latest of which appears online July 25 in the Journal of Tissue Engineering and Regenerative Medicine.
Modeled after the bone pieces they are meant to help replace, the implants were assembled onsite using three-dimensional robotic printing, a technology that uses a fine-point print head to push out a gel-like ink material. The material is printed onto a platform, and the printer repeats the process until two-dimensional layers stack up into a three-dimensional object, which is then superheated into its final ceramic form. Available for more than a decade, the technology has only of late been applied in medicine to print out replacement ears, skin, and heart valves.
“Our three-dimensional scaffold represents the best implant in development because of its ability to regenerate real bone,” says study senior investigator and biomedical engineer Paulo G. Coelho, DDS, PhD. “Our latest study results move us closer to clinical trials and potential bone implants for children living with skull deformations since birth, as well as for veterans seeking to repair damaged limbs,” adds Dr. Coelho, who is the Dr. Leonard I. Linkow Professor at NYU Dentistry and a professor of plastic surgery at NYU School of Medicine.
The scientists say their novel ceramics more closely resemble real bone shape and composition than other experimental bone implants in which plastic elasticizers are added to make the implant flex. Although the ability to flex offers some advantages, the plastic does not have the same healing ability as the NYU scaffold.
An important feature of the ceramic devices is that they are made of beta tricalcium phosphate, a compound of the same chemicals found in natural bone that makes the implants resorbable.
One of the secrets to the rapid growth of native bone with the NYU devices is a coating of dipyridamole, a blood thinner shown in other experiments to speed up bone formation by more than 50 percent. The chemical also attracts bone stem cells, which spur the formation of nourishing blood vessels and bone marrow within the newly grown bone. These soft tissues, researchers say, lend to their scaffold-grown bone the same flexibility as natural bone.
“Dipyridamole has proven to be key to the implant’s success,” says study co-investigator Bruce N. Cronstein, MD, the Dr. Paul R. Esserman Professor of Medicine at NYU School of Medicine, who perfected the drug’s use during device testing. Used for more than a half-century to prevent blood clots and treat stroke, dipyridamole has a long-standing safety record, says Dr. Cronstein, who also serves as the director of the Clinical and Translational Science Institute, and chief of the Division of Translational Medicine at NYU Langone Health. “And because the implant is gradually resorbed, the drug is released a little at a time and locally into the bone, not into the whole body, thereby minimizing risks of abnormal bone growth, bleeding, or other side effects.”
In the latest experiments, researchers used the test scaffolds to repair small holes surgically made in the skulls of mice and missing bone pieces as long as 1.2 centimeters in rabbit limbs and jaws.
The scientists found that on average 77 percent of each scaffold was resorbed by the mammal’s body 6 months after implantation. They also found that new bone grows into the lattice-like structural supports of the scaffold, which then dissolves. Some CT scans of the implant sites showed almost no trace of beta tricalcium phosphate, the three-dimensional–printed material of which the original implants were made.
Subsequent weight-bearing tests showed that the new bone was of equivalent strength as original, undamaged bone.
The investigators say their next studies will test the scaffolds, for which they have a patent pending, in larger animals. They caution that clinical trials are still several years away.
The Latest on: Ceramic implants
via Google News
The Latest on: Ceramic implants
- SINTX Technologies Looks Ahead To 2021 Opportunities and Beyondon January 12, 2021 at 10:37 am
SINTX Technologies Inc., an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, will celebrate its 25th year in existence in 2021. The company has a ...
- bangkok | Bangkok Post lifestyle, restaurants-and-food, thaion January 10, 2021 at 4:27 am
Siam Bangkok Dental offers general dentistry, orthodontics, gum treatments and dental implants. It also offers cosmetic dentistry along with general procedures. Promjai Dental Clinic offer a wide ...
- General Dental Devices And Equipment Market 2021 Global Trend, Segmentation and Opportunities, Forecast 2030on January 10, 2021 at 1:09 am
Major products include dental implants, dental crowns, bridges, dental filling caps, orthodontic cases, dentures (false teeth), casting machines, instrument delivery systems, ceramic furnaces ...
- Global Dental Ceramic Implants Market 2020 Industry Emerging Trend, Top Players, Revenue Insights to 2025on January 8, 2021 at 12:57 am
The latest market study titled Global Dental Ceramic Implants Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 combines market essential details, definitions, ...
- Hip Replacement Implants Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2027on January 6, 2021 at 3:03 pm
revision replacement implant. Based on material segmentation it covers metal-on-metal, metal-on-polyethylene, ceramic-on-metal, ceramic-on-polyethylene and ceramic-on-ceramic. Based on end user ...
- SINTX Technologies Looks Ahead to 2021 Opportunities and Beyondon January 6, 2021 at 7:17 am
In the third growth area of focus on biomedical implants, SINTX plans to expand its business in 2021 by leveraging its proprietary formulations of silicon nitride composites and coatings.
- SINTX Technologies Looks Ahead to 2021 Opportunities and Beyondon January 6, 2021 at 6:05 am
SALT LAKE CITY, Jan. 06, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment ...
- CeramTec Group acquires Dentalpoint AG to expand its ceramic Medtech leadershipon January 4, 2021 at 8:09 am
The CeramTec Group has taken the next step in the transformation into a medical technology corporation and acquired the Swiss specialist for ceramic dental implants, Dentalpoint ...
- Global Dental Ceramic Implants Market Regulatory Landscape Shaping Current And Future Strategies Of Companies 2021on December 31, 2020 at 2:18 am
The scope of Dental Ceramic Implants market report is to identify future trends, key strategies adopted and their recent developments, as well as to examine the increasing number of growth obstacles, ...
via Bing News